Neoen Valuation
Is N1N undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of N1N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: N1N (€39.22) is trading above our estimate of fair value (€4.6)
Significantly Below Fair Value: N1N is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for N1N?
Key metric: As N1N is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is N1N's PE Ratio? | |
|---|---|
| PE Ratio | 66.5x |
| Earnings | €90.70m |
| Market Cap | €6.03b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 19.5x |
| Enterprise Value/EBITDA | 22.8x |
| PEG Ratio | 3.2x |
Price to Earnings Ratio vs Peers
How does N1N's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 25.5x | ||
HRPK 7C Solarparken | 61.9x | 58.7% | €154.8m |
ABO clearvise | 19.4x | -47.3% | €131.5m |
RWE RWE | 8.4x | -11.1% | €23.7b |
MVV1 MVV Energie | 12.1x | n/a | €2.0b |
N1N Neoen | 66.5x | 20.6% | €6.0b |
Price-To-Earnings vs Peers: N1N is expensive based on its Price-To-Earnings Ratio (66.5x) compared to the peer average (25.5x).
Price to Earnings Ratio vs Industry
How does N1N's PE Ratio compare vs other companies in the European Renewable Energy Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: N1N is expensive based on its Price-To-Earnings Ratio (66.5x) compared to the European Renewable Energy industry average (16.2x).
Price to Earnings Ratio vs Fair Ratio
What is N1N's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 66.5x |
| Fair PE Ratio | 24.3x |
Price-To-Earnings vs Fair Ratio: N1N is expensive based on its Price-To-Earnings Ratio (66.5x) compared to the estimated Fair Price-To-Earnings Ratio (24.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €39.22 | €36.85 -6.0% | 12.1% | €39.90 | €28.50 | n/a | 9 |
| Nov ’25 | €39.06 | €36.85 -5.7% | 12.1% | €39.90 | €28.50 | n/a | 9 |
| Oct ’25 | €39.16 | €37.15 -5.1% | 11.6% | €39.90 | €28.50 | n/a | 10 |
| Sep ’25 | €38.38 | €37.15 -3.2% | 11.6% | €39.90 | €28.50 | n/a | 10 |
| Aug ’25 | €38.22 | €37.15 -2.8% | 11.6% | €39.90 | €28.50 | n/a | 10 |
| Jul ’25 | €36.96 | €37.15 +0.5% | 11.6% | €39.90 | €28.50 | n/a | 10 |
| Jun ’25 | €37.80 | €36.37 -3.8% | 12.3% | €39.90 | €28.50 | n/a | 10 |
| May ’25 | €28.84 | €30.85 +7.0% | 9.2% | €35.50 | €26.20 | n/a | 13 |
| Apr ’25 | €26.30 | €30.32 +15.3% | 10.4% | €35.50 | €26.20 | n/a | 13 |
| Mar ’25 | €23.90 | €31.22 +30.6% | 13.0% | €41.00 | €26.50 | n/a | 13 |
| Feb ’25 | €26.60 | €31.62 +18.9% | 13.4% | €41.00 | €26.50 | n/a | 13 |
| Jan ’25 | €30.06 | €31.31 +4.1% | 14.3% | €41.00 | €26.00 | n/a | 13 |
| Dec ’24 | €27.68 | €31.42 +13.5% | 14.1% | €41.00 | €26.00 | n/a | 13 |
| Nov ’24 | €24.76 | €32.06 +29.5% | 14.5% | €41.00 | €26.00 | €39.06 | 13 |
| Oct ’24 | €27.44 | €33.11 +20.7% | 13.0% | €41.00 | €27.00 | €39.16 | 11 |
| Sep ’24 | €27.30 | €33.11 +21.3% | 13.0% | €41.00 | €27.00 | €38.38 | 11 |
| Aug ’24 | €29.16 | €34.32 +17.7% | 16.0% | €46.70 | €27.00 | €38.22 | 12 |
| Jul ’24 | €28.98 | €33.95 +17.1% | 16.5% | €46.70 | €27.00 | €36.96 | 12 |
| Jun ’24 | €28.26 | €35.18 +24.5% | 16.0% | €46.70 | €27.30 | €37.80 | 11 |
| May ’24 | €27.04 | €36.91 +36.5% | 13.0% | €46.70 | €29.45 | €28.84 | 10 |
| Apr ’24 | €29.07 | €37.71 +29.7% | 12.1% | €46.70 | €29.45 | €26.30 | 10 |
| Mar ’24 | €29.56 | €40.82 +38.1% | 11.4% | €47.00 | €31.90 | €23.90 | 11 |
| Feb ’24 | €34.84 | €39.08 +12.2% | 18.6% | €47.00 | €20.00 | €26.60 | 12 |
| Jan ’24 | €37.79 | €39.07 +3.4% | 18.4% | €47.00 | €20.00 | €30.06 | 12 |
| Dec ’23 | €38.82 | €38.48 -0.9% | 17.7% | €45.90 | €20.00 | €27.68 | 12 |
| Nov ’23 | €34.90 | €38.19 +9.4% | 17.7% | €45.90 | €20.00 | €24.76 | 12 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Centrica
UK£6.4b
Operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally.
CENB
UK£1.52
7D
4.5%
1Y
-10.1%
AB Ignitis grupe
€1.4b
Engages in the generation and distribution of electricity and heat.
IGV0
€18.50
7D
-0.5%
1Y
-2.7%
Sembcorp Industries
S$9.2b
An investment holding company, engages in the production and supply of utilities services, and terminalling and storage of petroleum products and chemicals in Singapore, the United Kingdom, China, India, rest of Asia, the Middle East, and internationally.
SBOA
S$3.58
7D
-2.7%
1Y
3.5%